Format

Send to

Choose Destination
See comment in PubMed Commons below
Med Clin (Barc). 2011 May 28;136(15):688-93. doi: 10.1016/j.medcli.2010.02.006. Epub 2010 Apr 22.

[Influenza A, pregnancy and neuraminidase inhibitors].

[Article in Spanish]

Author information

1
Servicio de Farmacología Clínica, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, España. emontane.germanstrias@gencat.cat

Abstract

Following the explosion of the influenza A pandemic (H1N1) during the first semester of 2009, oseltamivir and zanamivir were used as the treatment of choice in the absence of rigorous clinical studies demonstrating their efficacy in the treatment and prophylaxis of this disease. Knowledge of seasonal influenza, flu pandemics and particularly the H1N1, which produces more severe infection and a higher mortality rate during pregnancy, led to the use of antiviral treatment despite the scarcity of clinical studies on their efficacy and effectiveness, mainly due to the influence of the media. This study reviewed the experimental and clinical studies performed on the safety of oseltamivir and zanamivir in pregnancy. Likewise, the recommendations made by the different health care and governmental authorities as well as other institutions and scientific and health care organizations on the therapeutic management and prophylaxis of influenza A 2009 in pregnant women were reviewed.

PMID:
20416906
DOI:
10.1016/j.medcli.2010.02.006
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center